3rd Merck Singulair Suit Stayed For Ruling In 1st Case

Law360, New York (April 17, 2009, 12:00 AM EDT) -- A Merck & Co. unit and Teva Pharmaceuticals USA Inc. have lodged a consent decree in Merck's third suit over a patent for blockbuster allergy and asthma drug Singulair, agreeing to resolve the spat based on the outcome of a pending suit between the two parties over the drug.

Magistrate Judge Tonianne J. Bongiovanni signed the consent decree Wednesday, administratively closing the case until final judgment is entered in a different action, known as “Singulair 1,” also filed in the U.S. District Court for the District...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.